Muscat – The groundbreaking procedure, which lasted approximately two hours, was conducted on a patient with a high-risk malignant tumor in the uterus.

Dr. Thuraya Rashid Al Rawahi, Senior Consultant in Oncology Surgery at the Royal Hospital and head of the medical team, explained that this operation represents a significant advancement in uterine tumor surgery within the Sultanate.

She highlighted that the procedure reduces the risks associated with the complete removal of lymph nodes and significantly shortens the duration of the operation, all while maintaining the accuracy of the treatment plan for uterine cancer.

Dr. Al Rawahi elaborated on the modern and precise nature of the lymph node removal technique. Prior to the operation, a radioactive substance is injected into the cervix to trace its path to the first lymph node that receives cancer cells. This targeted approach allows for the removal of only the sentinel lymph node, rather than all the lymph nodes in the pelvic area, as was previously the practice.
“This technique helps reduce the side effects of surgery, such as leg swelling, accelerates the healing process, and improves the patient’s quality of life,” Dr. Al Rawahi stated.

The successful execution of this procedure marks a qualitative leap in the surgical treatment of uterine tumors in Oman, paving the way for more advanced and less invasive cancer treatments in the region.
The new technique offers significant benefits for patients. It minimizes post-operative complications such as leg swelling, expedites the healing process, and ultimately enhances the patient’s quality of life, Dr. Al Rawahi pointed out.